As someone pointed out elsewhere, not only is lero
Post# of 148187
(Total Views: 584)
Posted On: 08/16/2020 11:12:54 AM
As someone pointed out elsewhere, not only is leronlimab "competing" against a placebo in the S/C trials, it is "competing" against SOC.
That raises the bar a little bit further taking these articles into account.
I feel if leronlimab is able to show statistical (not clinical) significance, then no one can deny that it is effective and safe.
That raises the bar a little bit further taking these articles into account.
I feel if leronlimab is able to show statistical (not clinical) significance, then no one can deny that it is effective and safe.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼